Brevan Howard Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,330	Closed	-$40.1K	–	1741
2025 Q1	$40.1K	Buy	+11,330	New	+$40.1K	﹤0.01%	1055
2024 Q1	–	Sell	-53,517	Closed	-$788K	–	947
2023 Q4	$788K	Buy	+53,517	New	+$788K	0.01%	265